SAFETY AND EFFICACY OF STATIN MANAGEMENT DURING GLECAPREVIR/PIBRENTASVIR TREATMENT FOR CHRONIC HEPATITIS C
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)32304-0
Abstract: Some statins are not recommended for concomitant use with glecaprevir/pibrentasvir (G/P) treatment for chronic hepatitis C virus infection. We analyzed the impact of switching to rosuvastatin or pravastatin compared to maintaining or interrupting current statin… read more here.
Keywords: safety efficacy; chronic hepatitis; pibrentasvir treatment; glecaprevir pibrentasvir ... See more keywords